BioXcel Therapeutics, Inc. — Investor Relations & Filings
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company that utilizes a proprietary artificial intelligence (AI) platform for drug development. The company focuses on creating transformative medicines in the fields of neuroscience and immuno-oncology. Its AI-driven approach aims to identify new therapeutic uses for existing molecules and novel compounds, potentially accelerating development timelines. The company's lead commercial product is IGALMI™ (dexmedetomidine sublingual film), approved for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. BioXcel's late-stage clinical pipeline includes programs investigating treatments for agitation in patients with Alzheimer's disease and other neuropsychiatric conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-15 | English | |
| 10-Q | 2026-05-15 | English | |
| 8-K - BioXcel Therapeutics, Inc. (0001720893) (Filer) | 2026-04-17 | English | |
| 8-K - BioXcel Therapeutics, Inc. (0001720893) (Filer) | 2026-04-01 | English | |
| 10-K - BioXcel Therapeutics, Inc. (0001720893) (Filer) | 2026-03-27 | English | |
| 8-K - BioXcel Therapeutics, Inc. (0001720893) (Filer) | 2026-03-27 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46352908 | FORM 8-K | 2026-05-15 | English | ||
| 46352910 | 10-Q | 2026-05-15 | English | ||
| 34662692 | 8-K - BioXcel Therapeutics, Inc. (0001720893) (Filer) | 2026-04-17 | English | ||
| 33133861 | 8-K - BioXcel Therapeutics, Inc. (0001720893) (Filer) | 2026-04-01 | English | ||
| 33066130 | 10-K - BioXcel Therapeutics, Inc. (0001720893) (Filer) | 2026-03-27 | English | ||
| 33058444 | 8-K - BioXcel Therapeutics, Inc. (0001720893) (Filer) | 2026-03-27 | English | ||
| 31461143 | 8-K Filing | 2026-02-12 | English | ||
| 31461095 | SCHEDULE 13G/A Filing | 2026-02-09 | English | ||
| 31461094 | 8-K Filing | 2026-02-06 | English | ||
| 31461111 | 8-K Filing | 2026-01-20 | English | ||
| 13071274 | OWNERSHIP DOCUMENT | 2026-01-13 | English | ||
| 13071275 | OWNERSHIP DOCUMENT | 2026-01-13 | English | ||
| 13071276 | OWNERSHIP DOCUMENT | 2026-01-13 | English | ||
| 13071277 | OWNERSHIP DOCUMENT | 2026-01-13 | English | ||
| 13071278 | OWNERSHIP DOCUMENT | 2026-01-13 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
|
Adaptogenics Health Corp.
Formulates and distributes functional mushroom and adaptoge…
|
ADPT | CA | Manufacturing |
|
Adastra Holdings
Manufacturer and supplier of ethnobotanical and processed c…
|
XTRX | CA | Manufacturing |
|
ADBIOTECH Co.,Ltd.
Develops IgY-based immune antibodies as alternatives to vac…
|
179530 | KR | Manufacturing |
|
ADC Therapeutics SA
Commercial-stage biotech developing antibody-drug conjugate…
|
ADCT | US | Manufacturing |
|
Addex Therapeutics Ltd.
Clinical-stage biopharma developing allosteric modulators f…
|
ADXN | CH | Manufacturing |
|
Adeshwar Meditex Limited
Manufacturer and exporter of medical disposables, surgical …
|
543309 | IN | Manufacturing |
|
ADIAL PHARMACEUTICALS, INC.
A clinical-stage biopharma developing genetically targeted …
|
ADIL | US | Manufacturing |
|
Adicet Bio, Inc.
Develops allogeneic gamma delta T cell therapies for cancer…
|
ACET | US | Manufacturing |
|
ADIM
Develops and manufactures human vaccines and biologics for …
|
4142 | TW | Manufacturing |
BioXcel Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34564/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34564 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34564 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34564 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34564}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BioXcel Therapeutics, Inc. (id: 34564)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.